Bionano Genomics (BNGO) Inventory (2017 - 2026)

Bionano Genomics has disclosed Inventory across 10 years of filings, most recently posting $5.3 million for Q1 2026.

• Inventory for Q1 2026 came in at $5.3 million, down 44.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (down 44.5% YoY), and the FY2025 annual result was $5.4 million, down 51.01% from the prior year.
• Inventory came in at $5.3 million for Q1 2026 at Bionano Genomics, down from $5.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $33.1 million in Q1 2023 to a low of $5.3 million in Q1 2026.
• The 5-year median for Inventory is $19.5 million (2024), against an average of $18.1 million.
• Across the five-year window, Inventory jumped 435.84% in 2022 and slumped 55.67% in 2025, its largest moves.
• Bionano Genomics' Inventory stood at $29.8 million in 2022, then decreased by 23.08% to $22.9 million in 2023, then plunged by 51.42% to $11.1 million in 2024, then plunged by 51.01% to $5.4 million in 2025, then decreased by 2.59% to $5.3 million in 2026.
• The last three Inventory figures came in at $5.3 million (Q1 2026), $5.4 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.